TCF7L2 and melanoma: Since the in silico analysis indicated the presence of LEF/TCF (T cell factor/Lymphoid Enhancer factor)-binding sites “A/T A/T CAAAG” within the SPARC proximal promoter, we explored whether endogenous LEF1 or TCF7L2 TFs could bind to this promoter region in melanoma cells.